News

Published on 23 Feb 2024 on Bloomberg via Yahoo Finance

US High-Grade Sales Top $60 Billion in Busiest Week Since 2022

Article preview image

(Bloomberg) -- US corporate investment-grade corporate bond sales surpassed $60 billion, marking the busiest week in nearly two years. The bond rush was propelled by a rare Friday offering from 3M Co. healthcare unit Solventum Corp.

Most Read from Bloomberg

BYD Unveils $233,450 EV Supercar to Rival Ferrari, LamborghiniZelenskiy Says 31,000 Troops Killed as Ukraine Seeks US Aid Decision Within MonthBuffett Says ‘Eye-Popping’ Results Unlikely With Record CashNorwegian Cruise Ship Halted at Mauritius Due to OutbreakTrump Advances 2024 Bid Besting Haley in Her Home State

Read the rest of the article
NASDAQ.CERE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)

Cerevel Therapeutics Holdings Inc (NASDAQ:CERE), a company dedicated to unraveling the mysteries ...

GuruFocus.com via Yahoo Finance 3 Apr 2024
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)

Cerevel Therapeutics Holdings Inc (NASDAQ:CERE), a company dedicated to unraveling the mysteries ...

GuruFocus.com via Yahoo Finance 6 Mar 2024
US High-Grade Sales Top $60 Billion in Busiest Week Since 2022

(Bloomberg) -- US corporate investment-grade corporate bond sales surpassed $60 billion, marking ...

Bloomberg via Yahoo Finance 23 Feb 2024
Stocks Rally as AI Craze Sweeps Across the World: Markets Wrap

(Bloomberg) -- The global stock rally powered ahead as Nvidia Corp.’s bullish outlook rekindled t...

Bloomberg via Yahoo Finance 22 Feb 2024
AbbVie Eyes Selling at Least $13 Billion of Bonds to Fund M&A

Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to he...

Bloomberg 21 Feb 2024
AbbVie eyes selling at least $13 billion of bonds to fund M&A

Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to he...

Crain s Chicago Business 21 Feb 2024
AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira

AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, an...

Market Watch 20 Feb 2024
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space - Biohaven (NYSE:BHVN)

RBC Capital Markets has initiated Biohaven Ltd BHVN, noting optimized development across programs...

Benzinga 16 Feb 2024
Insider Sell: Cerevel Therapeutics Holdings Inc's Chief Human Resources Officer Sells Company Shares

Kenneth Dipietro, Chief Human Resources Officer of Cerevel Therapeutics Holdings Inc (NASDAQ:CERE...

GuruFocus.com via Yahoo Finance 22 Dec 2023
Bristol to Purchase Schizophrenia Drugmaker for $14 Billion

Bristol Myers Squibb Co. agreed to buy schizophrenia drug developer Karuna Therapeutics Inc. for ...

Bloomberg 22 Dec 2023

Copyright Statfolio @ 2024

Social Accounts